Meeks, H. D., Burwinkel, B., Hamann, U., Marmé, F., & Brenner, H. (2016). BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. Journal of the National Cancer Institute, 108(2), . https://doi.org/10.1093/jnci/djv315
Chicago-Zitierstil (17. Ausg.)Meeks, Huong D., Barbara Burwinkel, Ute Hamann, Frederik Marmé, und Hermann Brenner. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute 108, no. 2 (2016). https://doi.org/10.1093/jnci/djv315.
MLA-Zitierstil (9. Ausg.)Meeks, Huong D., et al. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute, vol. 108, no. 2, 2016, https://doi.org/10.1093/jnci/djv315.